Biosimilars for retinal diseases: United States-Europe awareness survey (Bio-USER – survey)
- 19 February 2023
- journal article
- research article
- Published by Taylor & Francis in Expert Opinion on Biological Therapy
- Vol. 23 (8) , 851-859
Abstract
To assess the awareness of biosimilar intravitreal anti-vascular endothelial growth factor (VEGF) agents among retina specialists practicing in the United States (US) and Europe.A 16-question onlin...Keywords
This publication has 17 references indexed in Scilit:
- Need of education on biosimilars amongst ophthalmologists: combating the nocebo effectEye, 2019
- Ophthalmic biosimilars and biologics—role of endotoxinsEye, 2019
- Ophthalmic biosimilars: Lessons from IndiaIndian Journal Of Ophthalmology, 2019
- Understanding biosimilars and its regulatory aspects across the globe: an ophthalmology perspectiveBritish Journal of Ophthalmology, 2019
- Assessing awareness and attitudes of healthcare professionals on the use of biosimilar medicines: A survey of physicians and pharmacists in IrelandRegulatory Toxicology and Pharmacology, 2017
- Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty PhysiciansAdvances in Therapy, 2016
- Clinical trials for authorized biosimilars in the European Union: a systematic reviewBritish Journal of Clinical Pharmacology, 2016
- Attitudes towards subsequent entry biologics/biosimilars: A survey of Canadian rheumatologistsClinical Rheumatology, 2015
- Viewpoint: Knowledge and viewpoints on biosimilar monoclonal antibodies among members of the European Crohn's and Colitis OrganizationJournal of Crohn's and Colitis, 2014
- Brand Loyalty, Generic Entry and Price Competition in Pharmaceuticals in the Quarter Century after the 1984 Waxman-Hatch LegislationInternational Journal of the Economics of Business, 2011